Hydrochloric Acid

Hydrochloric Acid

SCHEMBL5233471

[Cl-].[Cl-].[Fe+2].[Fe].[O]

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL8959389 0.87
Hydrochloric Acid SCHEMBL7523995 0.87
SCHEMBL3197391 0.71
SCHEMBL518033 0.71
Hydrochloric Acid SCHEMBL8767180 0.71 CYP3A4 (0.33)
SCHEMBL29368502 0.71
Hydrochloric Acid SCHEMBL15216 0.71
Hydrochloric Acid SCHEMBL10947471 0.71 CYP3A4 (0.33)
Hydrochloric Acid SCHEMBL119032 0.71
SCHEMBL4537289 0.58

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1487839-B8 METHODS FOR PRODUCING NORGALANTHAMINE, AS WELL AS ISOMERS, SALTS AND HYDRATES THEREOF SANOCHEMIA PHARMAZEUTIKA AG (AT) 2007-06-13 EP disclosed
EP-1487839-B1 METHODS FOR PRODUCING NORGALANTHAMINE, AS WELL AS ISOMERS, SALTS AND HYDRATES THEREOF SANOCHEMIA PHARMAZEUTICA AG (AT) 2007-04-18 EP disclosed
EP-1681291-A1 Process for the preparation of norgalanthamine, its isomers, salts and hydrates Sanochemia Pharmazeutika Aktiengesellschaft (AT) 2006-07-19 EP disclosed
EP-1487839-A1 METHODS FOR PRODUCING NORGALANTHAMINE, AS WELL AS ISOMERS, SALTS AND HYDRATES THEREOF Sanochemia Pharmazeutica Aktiengesellschaft (AT) 2004-12-22 EP disclosed
WO-2003080623-A1 METHODS FOR PRODUCING NORGALANTHAMINE, AS WELL AS ISOMERS, SALTS AND HYDRATES THEREOF SANOCHEMIA PHARMAZEUTIKA AKTIENGESELLSCHAFT (AT) 2003-10-02 WO disclosed